Durability of clinical benefit with TMS PDF
By: Philip G. Janicak, Ziad Nahas, Sarah H. Lisanby, H. Brent Solvason, Shirlene M. Sampson, William M. McDonald, Lauren B. Marangell, Peter Rosenquist, W. Vaughn McCall, James Kimball, John P. O’Reardon, Colleen Loo, Mustafa H. Husain, Andrew Krystal, William Gilmer,
Sheila M. Dowd, Mark A. Demitrack, Alan F. Schatzberg
Background
Although transcranial magnetic stimulation (TMS) can be an effective acute antidepressant treatment, few studies systematically examine persistence of benefit.
